Last Posted: Jun 24, 2019
- Genetic variation at the coronary artery disease risk locus GUCY1A3 modifies cardiovascular disease prevention effects of aspirin.
Hall Kathryn T et al. European heart journal 2019 Jun - Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y 12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention.
Sibbing Dirk et al. JACC. Cardiovascular interventions 2019 Jun - P2Y12 Inhibitor Switching in Response to Routine Notification of CYP2C19 Clopidogrel Metabolizer Status Following Acute Coronary Syndromes.
Povsic Thomas J et al. JAMA cardiology 2019 May - Personalised antiplatelet therapy based on pharmacogenomics in acute ischaemic minor stroke and transient ischaemic attack: study protocol for a randomised controlled trial.
Zhang Xiao-Guang et al. BMJ open 2019 May 9(5) e028595 - Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study.
Kehm Rebecca D et al. Breast cancer research : BCR 2019 Apr 21(1) 52 - Pharmacogenomic considerations for antiplatelet agents: the era of precision medicine in stroke prevention and neurointerventional practice.
Bonney Phillip A et al. Cold Spring Harbor molecular case studies 2019 Apr 5(2) - Clinical Utility of CYP2C19 Genotyping to Guide Antiplatelet Therapy in Patients With an Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention.
Klein Melissa D et al. Arteriosclerosis, thrombosis, and vascular biology 2019 Feb ATVBAHA118311963 - Association Between ABCB1 Polymorphisms and Outcomes of Clopidogrel Treatment in Patients With Minor Stroke or Transient Ischemic Attack: Secondary Analysis of a Randomized Clinical Trial.
Pan Yuesong, et al. JAMA neurology 2019 2 0. - Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors.
Winter Max-Paul et al. European heart journal. Cardiovascular pharmacotherapy 2017 3(4) 221-234 - Recent Advances in Lynch Syndrome: Diagnosis, Treatment, and Cancer Prevention.
Yurgelun Matthew B et al. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 2018 May (38) 101-109
No hay comentarios:
Publicar un comentario